TIANAN MEDICARE (00383) releases interim financial results, with the company's attributable profit decreasing by 44.69% to 11.979 million Hong Kong dollars.

TIANAN MEDICARE (00383) announced its interim performance for the six months ending on June 30, 2025. The company reported revenue of 783 million Hong Kong dollars, a decrease of 4.67% year-on-year; attributable profit to owners of the company was 11.979 million Hong Kong dollars, a decrease of 44.69%; and basic earnings per share were 1.11 Hong Kong cents. The announcement stated that the decrease in revenue and attributable profit was mainly due to a decrease in operating revenue from the medical segment, an increase in non-cash fair value loss in investment properties, a decrease in employee benefits expenses, a net gain from unrealized exchange rate movements compared to a net loss in the first half of 2024, and a decrease in income tax expenses to offset.